A polyvalent group A streptococcal vaccine [ 2012 - 2015 ]

Research Grant

Researchers: Dr David Mcmillan (Principal investigator) ,  Dr Martina Sanderson-Smith ,  Prof Kadaba Sriprakash ,  Prof Louise Hafner ,  Prof Natkunam Ketheesan

Brief description Group A streptococcus (GAS) is a bacteria that causes a wide range of disease in humans. GAS diseases are more common in Australias Indigenous population, and other health and economically disadvantaged groups than more affluent groups. In this study we will evaluate the effectiveness of novel vaccine candidates designed to prevent infection from all strains of GAS.

Funding Amount $AUD 636,201.34

Funding Scheme Project Grants

Notes Standard Project Grant